I got this in my inbox recently...
The NIH on Monday announced that it is now accepting requests for human embryonic stem cell (hESC) lines to be approved for use in NIH-funded research. The review process and submission form were detailed earlier. The NIH Director also announced the members of a new working group of the Advisory Committee to the Director (ACD): the Working Group for Human Embryonic Stem Cell Eligibility Review. The Working Group, which will vet requests and advise [sic] the NIH Director, is being chaired by Jeffrey R. Botkin, M.D., M.P.H., professor of pediatrics at University of Utah's School of Medicine. He is also the associate vice president for research integrity at the University of Utah. Among the other Working Group members are: Pamela B. Davis, M.D., Ph.D., dean of the Case School of Medicine; David A. Grainger, M.D., M.P.H., University of Kansas School of Medicine-Wichita; Richard P. Lifton, M.D., Ph.D., Yale School of Medicine; Bernard Lo, M.D., UCSF; Terry Magnuson, Ph.D., University of North Carolina at Chapel Hill School of Medicine; and, Jeffrey C. Murray, M.D., University of Iowa Children's Hospital.
http://www.nih.gov/news/health/sep2009/od-21.htm
No comments:
Post a Comment